Ghost Tree Capital, LLC Aadi Bioscience, Inc. Transaction History

Ghost Tree Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$6.84 - $8.56 $684,000 - $856,000	100,000 Added 66.67%	250,000 $1.71 Million
Q1 2023 May 15, 2023	BUY	$6.85 - $13.0 $411,000 - $780,000	60,000 Added 66.67%	150,000 $1.09 Million
Q4 2022 Feb 14, 2023	SELL	$11.99 - $14.5 $1.32 Million - $1.6 Million	-110,000 Reduced 55.0%	90,000 $1.15 Million
Q3 2022 Nov 14, 2022	BUY	$12.03 - $14.22 $601,500 - $711,000	50,000 Added 33.33%	200,000 $2.83 Million
Q1 2022 May 16, 2022	SELL	$16.65 - $24.97 $832,499 - $1.25 Million	-50,000 Reduced 25.0%	150,000 $2.55 Million
Q4 2021 Feb 16, 2022	BUY	$19.32 - $29.02 $3.86 Million - $5.8 Million	200,000 New	200,000 $4.83 Million

12.6M

23.8K

Ticker AADI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,016,800
Market Cap $46.7M
Description
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.